Overview

PET Imaging of Dopamine in Healthy Study Participants

Status:
Completed
Trial end date:
2007-08-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure molecules on or in cells that interact with a chemical in the nervous system, called dopamine. Investigators will obtain two kinds of images of the brain-a position emission tomography (PET) scan and a magnetic resonance imaging (MRI) scan. Thirty-eight participants aged 18 to 45 will be enrolled in this study. They must have no history of medical or psychiatric illness, including substance abuse. Participants will have four appointments at NIH. On the first visit, they will undergo a physical exam, a medical history, and lab tests. The second and third visits will involve PET scans and the fourth visit will involve an MRI scan. Participants will be compensated up to $430 for their involvement in this study.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
alpha-Methyltyrosine
Amphetamine
Dextroamphetamine
Dopamine
Dopamine Agents
Fallypride